Citi upgraded CME Group (CME) to Buy from Neutral with a price target of $300, up from $275. Citi also placed an “upside 90-day catalyst watch” on the shares. The firm sees catalysts ahead for the shares from U.S. Treasury clearing, the OSTTRA joint venture, the Fanduel partnership, and annual variable dividend announcement. CME offers a “robust” capital return outlook over the next four months, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group upgraded to Buy from Neutral at Citi
- Crypto Currents: Bullish secures New York BitLicense from NYDFS
- CME Group price target lowered to $285 from $305 at UBS
- CME Group reports August ADV of 28.1M contracts
- Crypto Currents: U.S. eyes on-chain GDP data, Google plans layer-1 blockchain